Both in Pharmaceuticals
Ultragenyx Pharmaceutical vs Eton Pharmaceutcials
Over the past year RARE returned −53.0% and ETON returned +181.7%; their daily moves had a correlation of 0.13.
RARE −53.0% ETON +181.7%Growth of $1, one year, split-adjusted
| Metric | RARE | ETON |
|---|---|---|
| Price | $14.90 | $52.88 |
| Market cap | $1.47B | $1.51B |
| Today | −0.13% | −0.84% |
| 1 month | +14.0% | −3.7% |
| 6 months | −40.8% | +96.1% |
| Year to date | −35.2% | +212.7% |
| 1 year | −53.5% | +192.5% |
| Revenue growth (YoY) | +28.1% | +98.6% |
| Gross margin | 84.1% | 67.6% |
| Net margin | −43.0% | 30.8% |
| P/E (TTM) | — | 119.1× |
| Price / sales | 2.0× | 14.3× |
| Net cash | $292.0M | -$1.1M |
| Dividend yield | — | — |
| Volatility (60d) | 127.6% | 92.8% |
| Short % of float | 21.8% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).